- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/10 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 251/10
Total number of patents in this class: 54
10-year publication summary
2
|
4
|
5
|
5
|
2
|
4
|
1
|
2
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Anji Pharmaceuticals Inc. | 37 |
7 |
Poxel | 40 |
6 |
Poxel SAS | 23 |
5 |
BASF SE | 20458 |
4 |
Cv6 Therapeutics (NI) Limited | 31 |
4 |
Merck Patent GmbH | 5856 |
3 |
Daikin Industries, Ltd. | 9852 |
3 |
Alma Mater Studiorum - Universita di Bologna | 393 |
2 |
National Institute of Biological Sciences, Beijing | 95 |
2 |
Qingdao Kingagroot Chemical Compound Co., Ltd. | 146 |
2 |
Samsung Electronics Co., Ltd. | 139551 |
1 |
Central Glass Company, Limited | 1248 |
1 |
Dana-Farber Cancer Institute, Inc. | 2540 |
1 |
Fondazione Istituto Italiano di Technologia | 24 |
1 |
Fondazione Istituto Italiano di Tecnologia | 563 |
1 |
Hamari Chemicals, Ltd. | 32 |
1 |
Inscent, Inc. | 9 |
1 |
InterMune, Inc. | 95 |
1 |
Nankai University | 218 |
1 |
Novaled GmbH | 415 |
1 |
Other owners | 6 |